Bibliography
- NELSON HS: Advair: combination with fluticasone/salmeterol in the treatment of asthma. I Allergy Clin. Immunol. (2001) 107(2):398–416.
- •Review highlighting the advantages of combination therapy.
- DENT G: Ciclesonide (Byk Gulden). Carr:. Investig. Drugs (2002) 3(1):78–83.
- •Review of the therapeutic profile of ciclesonide.
- BIGGADIKE K, ANGELL RM, CM et al.: Selective plasma hydrolysis of glucocorticoid y-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. I Med. Chem. (2000) 43(1):19–21.
- PROCOPIOU PA, BIGGADIKE K, ENGLISH AF et al.: Novel glucocorticoid antedrugs possessing a 17I3-(y-lactone) ring. J. Med. Chem. (2001) 44(4):602–612.
- NORMAN P: New long acting 132 agonists. Expert Opin. Ther. Patents (2003) 13(2):273–277.
- RAY KP, FARROW S, DALY M et a/.: Induction of the E-selectin promoter by IL-1 and TNF-a and inhibition by glucocorticoids Biochem. .1. (1997) 328(2):707–715.
- DI LORENZO D, ALBERTINI A, ZAVA D: Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D. Cancer Res. (1991) 51(16):4470–4475.
- ADCOCK IM: Glucocorticoid-regulated transcription factors. Pulm. Pharmacol Ther. (2001) 114:211–219.
- ••Review defining the desired and undesiredeffects of glucocorticoid agonists.
- GlaxoSmithKline press release. Theravance and GlaxoSmithKline form alliance to develop next generation respiratory medicines. 6 January (2003).